Summary:
Women's Health Texas is conducting this research study to learn more about a new investigational, non-hormonal drug called elinzanetant. The purpose of the study is to see if elinzanetant may reduce the number and intensity of hot flashes in postmenopausal women. Overall, this study will consist of 9 visits to the study site and one phone visit over a period of 9 months.
Qualified Participants Must:
- Be postmenopausal women between 40-65 years of age.
- Have moderate to severe hot flashes and be seeking treatment.
Qualified Participants May Receive:
Qualified Participants May Receive:
- No-cost investigational medication.
- No-cost study-related medical care.
- Compensation up to $800.